The therapeutic potential of NS3 protease inhibitors in HCV infection

Author： Goudreau Nathalie   Llinàs-Brunet Montse  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.9, 2005-09, pp. : 1129-1144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery of Small-Molecule Inhibitors of HCV NS3-4A Protease as Potential Therapeutic Agents against HCV Infection

By  

Current Medicinal Chemistry, Vol. 12, Iss. 20, 2005-09 ,pp. : 2317-2342

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR and Docking Studies of HCV NS3 Serine Protease Inhibitors

By  

Medicinal Chemistry, Vol. 9, Iss. 6, 2013-09 ,pp. : 774-805

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Novel HCV NS3-4A Protease Inhibitors

By Hui Chang-Ye   Xie Xiao-Bing   Cao Hong   Huang Sheng-He  

Anti-Infective Agents, Vol. 11, Iss. 2, 2013-07 ,pp. : 125-135

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Novel HCV NS3-4A Protease Inhibitors

By  

Anti-Infective Agents, Vol. 11, Iss. 2, 2013-07 ,pp. : 125-135

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of an Amphiphilic Capping Group in Covalent and Non-Covalent Dipeptide Inhibitors of HCV NS3 Serine Protease

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 113-117

Bentham Science Publishers

Access to resources Recommend Favorite